Back to Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc.

All insiders

18 insiders

InsiderRole% of sharesShares heldLast trade
Deschatelets PascalChief Scientific Officer0.92%1,177,222Jan 28, 2026
Francois CedricChief Executive Officer · Director0.62%798,783Mar 11, 2026
Machiels AlecDirector0.30%384,989Jan 1, 2026
Dunlop A. SinclairDirector0.13%161,567Jan 1, 2026
Sullivan Timothy EugeneChief Financial Officer0.12%152,041Jan 28, 2026
Watson David O.General Counsel0.11%144,517Jan 28, 2026
Boucher KelleyChief People Officer0.10%127,804Jan 28, 2026
Nicholson NurChief Technical Officer0.09%116,338Jan 28, 2026
DeLong Mark JeffreyChief Business & Strat Officer0.09%114,591Feb 11, 2026
MELTZER LESLIEChief Research and Development0.08%107,024Jan 28, 2026
Baumal CarolineChief Medical Officer0.07%86,527Jan 22, 2026
Chopas James GeorgeVP/Chief Accounting Officer0.05%65,955Jan 28, 2026
FONTEYNE PAUL R.Director0.02%30,666Jan 1, 2026
Chan GeraldDirector0.02%25,666Jan 1, 2026
O'Brien Stephanie MonaghanDirector0.02%25,666Jan 1, 2026
Walbert KeliDirector0.01%17,051Jan 1, 2026
Dolsten MikaelDirector0.01%14,312Feb 27, 2026
WHEELER CRAIG ADirector0.00%0May 14, 2026
← PrevPage 1 of 1Next →